Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Elbaz, Judith"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Addeo, Alfredo, Hochmair, Maximilian, Janzic, Urska, Dudnik, Elizabeth, Charpidou, Andriani, P��u��an��ski, Adam, Ciuleanu, Tudor, Donev, Ivan Shterev, Elbaz, Judith, Aar��e, J��rgen, Ott, Ren��, Peled, Nir
Supplemental material, sj-docx-3-tam-10.1177_17588359211059874 for Treatment patterns, testing practices, and outcomes in the pre-FLAURA era for patients with EGFR mutation-positive advanced NSCLC: a retrospective chart review (REFLECT) by Alfredo Ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f38e56c88a0cab1bda3ad0de051c9868
Autor:
Addeo, Alfredo, Hochmair, Maximilian, Janzic, Urska, Dudnik, Elizabeth, Charpidou, Andriani, P��u��an��ski, Adam, Ciuleanu, Tudor, Donev, Ivan Shterev, Elbaz, Judith, Aar��e, J��rgen, Ott, Ren��, Peled, Nir
Supplemental material, sj-docx-2-tam-10.1177_17588359211059874 for Treatment patterns, testing practices, and outcomes in the pre-FLAURA era for patients with EGFR mutation-positive advanced NSCLC: a retrospective chart review (REFLECT) by Alfredo Ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c4e5ec2095b7843e53b58e9c4fff144
Autor:
Addeo, Alfredo, Hochmair, Maximilian, Janzic, Urska, Dudnik, Elizabeth, Charpidou, Andriani, P��u��an��ski, Adam, Ciuleanu, Tudor, Donev, Ivan Shterev, Elbaz, Judith, Aar��e, J��rgen, Ott, Ren��, Peled, Nir
Supplemental material, sj-docx-1-tam-10.1177_17588359211059874 for Treatment patterns, testing practices, and outcomes in the pre-FLAURA era for patients with EGFR mutation-positive advanced NSCLC: a retrospective chart review (REFLECT) by Alfredo Ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc6432eeca431bb9f710021226d701c2
Autor:
Addeo, Alfredo, Hochmair, Maximilian, Janzic, Urska, Dudnik, Elizabeth, Charpidou, Andriani, P��u��an��ski, Adam, Ciuleanu, Tudor, Donev, Ivan Shterev, Elbaz, Judith, Aar��e, J��rgen, Ott, Ren��, Peled, Nir
Supplemental material, sj-docx-5-tam-10.1177_17588359211059874 for Treatment patterns, testing practices, and outcomes in the pre-FLAURA era for patients with EGFR mutation-positive advanced NSCLC: a retrospective chart review (REFLECT) by Alfredo Ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27f622fd45d8fb4659af30fffbef4799
Autor:
Addeo, Alfredo, Hochmair, Maximilian, Janzic, Urska, Dudnik, Elizabeth, Charpidou, Andriani, P��u��an��ski, Adam, Ciuleanu, Tudor, Donev, Ivan Shterev, Elbaz, Judith, Aar��e, J��rgen, Ott, Ren��, Peled, Nir
Supplemental material, sj-docx-4-tam-10.1177_17588359211059874 for Treatment patterns, testing practices, and outcomes in the pre-FLAURA era for patients with EGFR mutation-positive advanced NSCLC: a retrospective chart review (REFLECT) by Alfredo Ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d635c085cdf68a2fc16ddd94285ebe78
Introduction: For epidermal growth factor receptor mutation-positive (EGFRm) non-small-cell lung cancer (NSCLC), EGFR-tyrosine kinase inhibitors (EGFR-TKIs) are the preferred first-line (1 L) treatment in the advanced setting. Osimertinib, a third-ge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::8b8c11e8e4118ca32e3765aa99ce1a93
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3032440
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3032440
Autor:
Butovsky, Elena, Juknat, Ana, Elbaz, Judith, Shabat-Simon, Maytal, Eilam, Raya, Zangen, Abraham, Altstein, Miriam, Vogel, Zvi
Publikováno v:
In Molecular and Cellular Neuroscience 2006 31(4):795-804
